Latest news for HUMBL (OTC:HMBL) Stock

HUMBL Inc is a digital commerce company. It operates a platform to connect consumers, businesses, and governments in the digital economy. HUMBL provides simple tools and packaging for complex new technologies such as blockchain, in the same way that previous cycles of e-commerce and the cloud were more simply packaged by companies such as Facebook, Apple, Amazon and Netflix over the past several decades. The company's segment includes Consumer and Commercial. It generates maximum revenue from the Consumer segment. They account for revenues based on the verticals in which they were earned, the three principal verticals being HUMBL Wallet, and HUMBL Marketplace, HBS.

cannabis shacking hands (lindsayfox and Tusumi by Pixabay)(7)

Cannabis

News

Movers & Shakers

AFCG

CSE:HMBL

CSE:IAN

CSE:MMEN

CSE:MRMD

CWBHF

CWEB

FLGC

HMBL

HUMBF

ITHUF

KAVL

MMNFF

MRMD

PCLOF

TSXV:PCLO

UNRIVALED BRANDS INC by Unrivaled Brands, Inc.

UNRV

Top Cannabis Industry Leaders Who Took The Reins In 2023

HUMBL Inc

Needham analyst Mike Cikos reiterates N-able (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NABL#NYSE">NABL</a>) with a Buy and maintains $16.5 price target.

Price Target

Reiteration

Analyst Ratings

NABL

Needham Reiterates Buy on N-able, Maintains $16.5 Price Target

Earnings

Earnings Beats

Global Blue Gr Holding Q2 Sales €132.000M Beat €131.250M Estimate

Ahead of the potential market correction,&nbsp;Brian Arcese&nbsp;from&nbsp;Foord Asset Management&nbsp;has highlighted concerns over the U.S. economic growth and corporate earnings. These factors could trigger a correction if they continue to slow down.
What Happened: Arcese warned that a market correction could occur if U.S. GDP or earnings growth slows. Arcese noted that the S&amp;P 500 has&nbsp;been &#8220;expensive for quite a&nbsp;while,&#8221; with a price-to-earnings ratio exceeding 27, CNBC <a href="https://www.cnbc.com/2024/11/22/sp-correction-could-happen-if-gdp-or-earnings-growth-slows-says-asset-manager.html">reported</a>&nbsp;on Friday.
"We do think that a correction would be healthy, but you will need some type of catalyst for that correction to take place,&#8221; he said, highlighting two potential catalysts for a correction: slowing economic growth and inflation increases. 
U.S. GDP growth was less than anticipated in the third quarter, and&nbsp;inflation rose to 2.6% in&nbsp;October, as per recent data. He emphasized that high corporate earnings expectations, particularly outside IT and communication services, could also trigger a correction if growth slows.
See Also:&nbsp;<a href="https://www.benzinga.com/24/11/42079585/meta-google-and-microsoft-bet-big-on-ai-with-skyrocketing-capex-budgets-but-jensen-huangs-nvidia-poised-to-be-the-biggest-winner-says-analyst-only-game-in-town-with-1-trillion-of-ai-capex?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Dan Ives Expects &#8216;Drop The Mic Performance&#8217; Tomorrow From Nvidia: Here&#8217;s Why</a>
Arcese remarked on the unusual combination of factors like GDP growth, earnings growth, and&nbsp;falling inflation and interest rates, which he described as rare. He noted that while utilities are more expensive than before, they remain less costly than the broader market, with growth driven by increased electricity demand from data centers and AI advancements.
Why It Matters: The concerns raised by Arcese align with recent warnings from other financial experts.&nbsp;David Einhorn, founder of Greenlight Capital<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42087680/billionaire-investor-david-einhorn-calls-it-most-expensive-market-of-all-time-as-sp-500-gains-4-since-trumps-win-really-really-pricey">, recently labeled the current market</a> as &#8220;the most expensive of all time,&#8221; citing the high Shiller cyclically adjusted price-to-earnings ratio.
Similarly,&nbsp;Stifel&#8217;s&nbsp;Barry Bannister predicted a <a href="https://www.benzinga.com/markets/equities/24/09/40974512/stifel-warns-of-12-market-drop-by-end-of-2024-as-s-p-500-faces-high-valuations-and-speculative-r">12% market drop</a> by the end of 2024, driven by high valuations and speculative risks. The S&amp;P 500&#8217;s price-to-earnings multiple is nearing historic highs, reminiscent of previous market peaks.
Despite these concerns,&nbsp;<a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42024472/goldman-sachs-us-to-dominate-2025-growth-with-2-5-gdp-boost-euro-area-will-struggle">Goldman Sachs&nbsp;forecasts </a>strong U.S. economic growth in 2025, with a 2.5% GDP boost, suggesting potential resilience in the face of current market challenges.
Price Action: As of Friday, according to <a href="https://pro.benzinga.com">Benzinga Pro</a>, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) that tracks the S&amp;P 500 closely witnessed a 25.60% increase in its year-to-date (YTD) returns while Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) saw a hike of 25.43%. However, during pre-market hours on Friday, both the ETFs were trading slightly lower.
On Friday, <a href="https://www.benzinga.com/24/11/42133364/us-stocks-on-edge-but-likely-to-end-the-week-in-the-green-trumps-treasury-pick-in-focus-expert-says-case-for-fed-pause-in-december-getting-stronger">futures show a decline across major indices</a>: Nasdaq 100 down 0.51%, S&amp;P 500 down 0.40%, Dow Jones down 0.29%, and R2K down 0.08%.
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42082077/if-you-bought-bitcoin-at-387-a-decade-ago-you-would-now-have-more-than-2x-the-average-us-retirement-savings?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">If You Bought Bitcoin At $387 A Decade Ago, You Would Now Have More Than 2X The Average US Retirement Savings</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Analyst Color

Markets

General

Potential 'Healthy Correction' For An 'Expensive' Market Looms As US Economic Growth And Earnings Slow, Says Asset Manager: S&P 500, Nasdaq Futures Trade Lower In Premarket

KBR Inks Pact With AMUFERT For The Development Of A New Ammonia Plant In Soyo, Angola

The company said its subsidiary Beneficient Company Holdings, L.P. consummated a previously announced transaction pursuant to which approximately $35 million of its preferred equity was redesignated as non-redeemable, resulting in the addition of approximately $35 million of permanent equity on its balance sheet.&nbsp;

BENF

Beneficient Says It Believes It Now Has Stockholders' Equity Of At Least $2.5M, The Amount Required To Regain Compliance With Nasdaq's Minimum Stockholders' Equity Requirement

SCLX

Scilex Holding Company Announces Receipt Of Notice From Nasdaq For Its Failure To File Its Quarterly Report On Form 10-Q For The Quarter Ended September 30

Needham analyst Tom Nikic initiates coverage on Skechers USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) with a Hold rating.

Initiation

Needham Initiates Coverage On Skechers USA with Hold Rating

This milestone follows Tri Pointe Homes' entry into the greater Orlando market, a strategic expansion driven by the area's robust growth and demand for high-quality housing options.

Tri Pointe Homes Says It Closed On First Land Acquisition In The Greater Orlando Market, Marking The Homebuilder's Debut In Minneola's Sugarloaf Mountain Community

Needham analyst Tom Nikic initiates coverage on Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) with a Hold rating.

LULU

Needham Initiates Coverage On Lululemon Athletica with Hold Rating

Needham analyst Tom Nikic initiates coverage on Crocs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) with a Buy rating and announces Price Target of $116.

CROX

Needham Initiates Coverage On Crocs with Buy Rating, Announces Price Target of $116

Needham analyst Tom Nikic initiates coverage on Steven Madden (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOO#NASDAQ">SHOO</a>) with a Hold rating.

SHOO

Needham Initiates Coverage On Steven Madden with Hold Rating

U.S. stocks could open on a negative note on Friday after futures showed tentativeness on Friday. Investors turned their focus to cyclical stocks and themes, moving on from their <a href="https://www.benzinga.com/24/11/42058223/us-stocks-likely-to-open-in-red-as-geopolitical-tension-weigh-on-investor-sentiment-wharton-economist-says-market-trajectory-will-heavily-depend-on-trumps-tariff-plans">focus on the Trump trade</a> after the election results.
Futures of the three major indices were mixed, with the Nasdaq heading lower after AI giant Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) posted its highly-anticipated third-quarter results.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.51%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.40%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.29%</td>
</tr>
<tr>
<td>R2K</td>
<td>-0.08%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Friday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) edged lower by 0.34% to $591.68 and the Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) declined 0.39% to $503.03, according to <a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Cues From Last Session:
U.S. stocks ended Thursday in the green, with the Dow Jones surging by over 450 points, while the tech-heavy Nasdaq registered marginal gains.
Crude oil futures continued on their upward trajectory amid rising tensions between Russia and Ukraine.
Treasury yields eased marginally on mixed data and the declining probability of the Federal Open Market Committee (FOMC) cutting interest rates in December.
On the economic data front, U.S. existing home sales gained 3.5% from the previous month to an annualized rate of 3.96 million in October. The Philadelphia Fed Manufacturing Index fell to -5.5 in November from 10.3 in the previous month, and compared to market estimates of 8.
Initial jobless claims declined by 6,000 from the previous week to 213,000 in the week ending Nov. 16.
Most sectors on the S&amp;P 500 closed on a positive note, with utilities, financials, and consumer staples stocks recording the biggest gains on Thursday.
However, consumer discretionary and communication services stocks bucked the overall market trend, closing the session lower.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.03%</td>
<td>18,972.42</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.53%</td>
<td>5,948.71</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>1.06%</td>
<td>43,870.35</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.65%</td>
<td>2,364.02</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Powell's relatively hawkish tone has investors cautious in the markets. With the Trump trade losing steam, the focus is now on the President-elect's Treasury pick.
"In focus currently is President-elect Trump's pick for the influential post of US Treasury Secretary. Given the large US budget deficit, investors will probably want to see a safe pair of hands being chosen," ING analysts said in a note.
With the next rate cut now a coin toss, the U.S. dollar could see a correction. According to ING analyst Francesco Pesole, the dollar is "testing the limit" of its longs and traders should exercise caution for the time being.
"Powell seemed to put greater emphasis on the strength of the economy&nbsp;and how that allows the central bank to approach the upcoming policy decisions ‘carefully'."
CME Group's FedWatch tool <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">reflected</a> the fall in sentiment for another rate cut next month, with its probability declining to 59.6% from 72.2%.
&#8220;The case for a Fed pause in December is getting stronger and Fed officials are communicating that they are open to it going into the next meeting,&#8221; Kathy Jones, chief fixed income strategist at Schwab, said in a recent note.
&#8220;It will come down to employment and inflation data.&#8221;
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How To Trade Futures</a>
Upcoming Economic Data
Friday's major economic updates include:
<ul>
<li>S&amp;P U.S. Services and Manufacturing Purchasing Manager's Index will be released at 9:45 a.m. ET.</li>
<li>Consumer sentiment data will be released at 10 a.m. ET.</li>
<li>Fed Gov. Michelle Bowman will speak at 6:15 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>The Gap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) stock surged 15% in premarket trading after the <a href="https://www.benzinga.com/news/earnings/24/11/42125007/gap-stock-soars-on-better-than-expected-q3-results-raised-fy-guidance-details">retailer raised its annual target</a> with a "strong" outlook for the holiday season.</li>
<li>MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) stock surged over 2% in premarket trading on Friday as Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) <a href="https://www.benzinga.com/24/11/42130693/bitcoins-path-to-100k-inevitable-but-leverage-to-the-gills-warns-mike-novogratz-predicts-80k-correction-ahead">inched closer to the $100,000 mark</a>. Robinhood Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) stock was also up over 0.5%.</li>
<li>Reddit Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) stock <a href="https://www.benzinga.com/24/11/42132644/reddit-falls-7-in-afterhours-as-advance-plans-stake-sale-technicals-show-strong-support-but-selling-pressure-persists-at-overbought-levels">fell over 7% in premarket trading</a> after the social media company amid Advance's stake sale announcement.</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) stock fell over 4.7% on Thursday after the U.S. Department of Justice (DOJ) pushed forward with its demands for <a href="https://www.benzinga.com/24/11/42131274/why-googles-chrome-battle-isnt-just-about-search-gene-munster-calls-it-a-tough-day-for-big-tech-on-the-regulatory-front">Google to divest</a> the Chrome web browser.</li>
<li>Investors are awaiting earnings results from Destination XL Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) and Global Blue Group Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GB#NYSE">GB</a>) today.</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil futures rose in the early New York session, surging by 0.61% to hover around $70.54 per barrel.
The 10-year Treasury note yield eased to 4.396%.
Most of the major Asian markets ended in the green on Friday, but European markets were mixed in early trading.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42130693/bitcoins-path-to-100k-inevitable-but-leverage-to-the-gills-warns-mike-novogratz-predicts-80k-correction-ahead">Bitcoin&#8217;s Path To $100K &#8216;Inevitable&#8217; But Crypto Community Is &#8216;Leveraged To The Gills,&#8217; Warns Galaxy&#8217;s Mike Novogratz, Predicts Correction To $80K Ahead</a></li>
</ul>
Photo courtesy: Wikimedia

Equities

Futures

Economics

Federal Reserve

Pre-Market Outlook

Movers

Trading Ideas

$BTC

DXLG

GOOG

GOOGL

HOOD

MSTR

NVDA

RDDT

US Stocks Set To Open Lower On Friday As Investors Eye Cyclical Stocks: Trump's Treasury Pick In Focus, Expert Says Case For Fed Pause In December 'Getting Stronger'

Needham analyst Tom Nikic initiates coverage on Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) with a Buy rating and announces Price Target of $218.

DECK

Needham Initiates Coverage On Deckers Outdoor with Buy Rating, Announces Price Target of $218

Shares of Elastic N.V (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter financial results and issued FY25 guidance <a href="https://www.benzinga.com/quote/ESTC/news">above estimates</a>.
Elastic reported quarterly earnings of 59 cents per share which beat the analyst consensus estimate of 38 cents per share. The company reported quarterly sales of $365.361 million which beat the analyst consensus estimate of $355.900 million.
Elastic shares jumped 29.1% to $121.46 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) gained 67.1% to $0.9855 in pre-market trading after the company announced an agreement with the US HHS department for an extension towards its cooperative research and development.</li>
<li>Wellchange Holdings Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WCT#NASDAQ">WCT</a>) rose 50.4% to $1.88 in pre-market trading after dipping 62% on Thursday.</li>
<li>Beneficient  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BENF#NASDAQ">BENF</a>) gained 30.7% to $1.15 in pre-market trading after gaining around 7% on Thursday.</li>
<li>SKK Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKK#NASDAQ">SKK</a>) gained 25.4% to $1.38 in pre-market trading after declining around 75% on Wednesday.</li>
<li>Exicure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) gained 19.4% to $12.98 in pre-market trading.</li>
<li>The Gap, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) gained 14.9% to $25.33 in pre-market trading after reporting better-than-expected third-quarter results.</li>
<li>Global Blue Group Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GB#NYSE">GB</a>) gained 10.4% to $6.90 in pre-market trading.</li>
<li>Kairos Pharma, Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#NYSE">KAPA</a>) climbed 8.7% to $1.63 in pre-market trading.</li>
<li>Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) gained 7% to $153.01 in pre-market trading after the company reported better-than-expected third-quarter EPS results..</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Knightscope, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) shares tumbled 41.8% to $10.64 in pre-market trading after the company announced the pricing of $12.1 million public offering.</li>
<li>Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) fell 33.3% to $9.01 in pre-market trading.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares fell 27.2% to $0.1430 in pre-market trading after the company announced its board approved a 1-for-35 reverse stock split.</li>
<li>Procaps Group S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROC#NASDAQ">PROC</a>) declined 18.7% to $0.90 in pre-market trading as the company said it faced Nasdaq delisting threat due to Form 20-F filing delay.</li>
<li>Carter Bankshares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARE#NASDAQ">CARE</a>) shares fell 10.6% to $16.86 in pre-market trading.</li>
<li>Real Messenger Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMSG#NASDAQ">RMSG</a>) dipped 16.2% to $3.51 in pre-market trading after jumping over 10% on Thursday.</li>
<li>Aptose Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APTO#NASDAQ">APTO</a>) fell 13.9% to $0.21 in pre-market trading after dipping more than 10% on Thursday.</li>
<li>Envoy Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCH#NASDAQ">COCH</a>) shares dipped 12.7% to $1.92 in pre-market trading.</li>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) fell 7.3% to $146.50 in pre-market trading. Reddit's shareholder, Advance Magazine Publishers Inc. plans to sell as much as $1.2 billion of the company's stake, reported Bloomberg on Friday morning. The company is said to be offering 7.8 million shares in between the range of $145.38-$148.54 each.</li>
<li>Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) fell 5.7% to $639.95 in today's pre-market trading. Intuit reported upbeat results for its first-quarter results, but issued weak forecast for the current quarter.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42131399/dow-surges-over-450-points-investor-sentiment-improves-fear-greed-index-moves-to-greed-zone">Dow Surges Over 450 Points As Nvidia Climbs Post-Earnings, Google, Amazon Slip: Fear Index Shifts To &#8216;Greed&#8217; Zone</a></li>
</ul>

AMIX

APTO

CARE

CETX

Envoy Medical, Inc. - Class A Common Stock

COCH

ESTC

INTU

KAPA

KSCP

PROC

RMSG

ROST

VRPX

XCUR

Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket

Needham analyst Tom Nikic initiates coverage on Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) with a Buy rating and announces Price Target of $27.

Needham Initiates Coverage On Foot Locker with Buy Rating, Announces Price Target of $27

Needham analyst Mike Matson downgrades TransMedics Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) from Buy to Hold and maintains the price target from $109 to $109.

Downgrades

TMDX

Needham Downgrades TransMedics Gr to Hold, Maintains Price Target to $109

Needham analyst Tom Nikic initiates coverage on Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a Buy rating and announces Price Target of $84.

Needham Initiates Coverage On Nike with Buy Rating, Announces Price Target of $84

ZKH Group Inks Pact With With Zhejiang Tmall Technology Co. To Establish Cooperation Of GBB Platform With Zhejiang Tmall's Industrial Product Platform; Agreement Will Be Effective Until October 31

Needham analyst Tom Nikic reiterates Under Armour (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAA#NYSE">UAA</a>) with a Hold.

Needham Reiterates Hold on Under Armour

Needham analyst Tom Nikic initiates coverage on On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) with a Buy rating and announces Price Target of $64.

ONON

Needham Initiates Coverage On On Holding with Buy Rating, Announces Price Target of $64

HUMBL ( ($HMBL) ) just unveiled an announcement. HUMBL, Inc. has announced the issuance of a U.S. patent for its innovative blockchain-based curren...

HUMBL Secures U.S. Patent for Blockchain Innovation

Press Releases

HUMBL Announces Launch of Government Digital Wallet with the County of Santa Cruz

HUMBL Launches New HUMBL.com Platform and Verification Features

HUMBL and the Arena Football League (AFL) Launch Innovative Digital Ticketing Program on Blockchain

HUMBL Announces Purchase of HUMBL Financial by Avrio, to Drive a Range of Financial Products and Services into the Global Markets

Minnesota Myth of the AFL Signs Merchandising Deal with HUMBL Authentics

HUMBL Reduces Stockholders' Deficit by over $33 Million Since the End of Calendar Year 2022

HUMBL and the Oregon BlackBears Deliver Innovative Digital Ticketing Program

HUMBL Issued U.S. Patent for System and Method for Transferring Currency Using Blockchain

HUMBL

In 2023, top executives in the cannabis industry continued to play a pivotal role in shaping the future of the rapidly growing market.



These executives championed sustainability, social responsibility and inclusive business practices on the path to creating a more diverse and equitable cannabis industry. Their leadership contributed to the normalization of cannabis, driving mainstream acceptance and reshaping public perceptions.



Humble &amp; Fume Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/HMBL#CSE">HMBL</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/HUMBF#OTCQX">HUMBF</a>), kicked off 2023 by <a href="https://www.benzinga.com/markets/cannabis/23/01/30406998/key-marijuana-executive-changes-you-should-know-about-this-company-got-a-new-ceo-more-news">naming Jakob Ripshtein</a> as its new CEO. He replaced Joel Toguri. Under Ripshtein's guidance, the company reported <a href="https://www.benzinga.com/markets/cannabis/23/10/35463550/canadas-top-weed-accessory-distributor-will-ramp-up-in-california-reports-2023-sales-uptick">positive financial results</a> for the full year of 2023. The company plans to intensify its efforts in the California cannabis sector going forward.



In February, cannabis social media platform WeedTube <a href="https://www.benzinga.com/markets/cannabis/23/02/31022325/keeping-up-with-cannabis-key-industry-and-executive-changes-you-should-know-about">elected Maggie Adair</a> as its new CEO. Adair, a graduate of George Washington University with degrees in Communications and Political Management, has had a successful career in the political realm of Washington D.C., working for top political officials in media, campaigns, <a href="https://www.benzinga.com/markets/cannabis/23/02/30989888/meet-the-new-ceo-of-weedtube-a-political-powerhouse-with-a-passion-for-cannabis">and the tech field.</a>



Cannabis multi-state operator MariMed.'s (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTCQX">MRMD</a>) (CSE:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#CSE">MRMD</a>) board of directors tapped Edward Gildea to serve as their chairman and <a href="https://www.benzinga.com/markets/cannabis/23/03/31195566/latest-executive-changes-in-marijuana-industry-new-appointments-more">Jon Levine as CEO in March.</a> Levine, the company&#8217;s co-founder and president, who was one of the speakers at April&#8217;s Cannabis Capital Conference. Levin took over as interim CEO after the untimely death of co-founder, chairman and CEO Bob Fireman. The company, one of analyst's favorite stocks closed a $58.7 million secured credit facility with a U.S. chartered bank in November and is now <a href="https://www.benzinga.com/markets/cannabis/23/11/35874567/one-of-analysts-favorite-marijuana-stocks-says-farewell-to-debt-closes-58-7m-refinancing-deal">expected to "generate significant cash savings."</a>



July was a busy month in the cannabis sector with <a href="https://www.benzinga.com/markets/cannabis/23/07/33280078/top-talent-to-lead-two-new-us-marijuana-markets-and-latest-key-hires-in-cannabis-industry">several companies naming new CEOs:</a>



<ul>
<li>Sabas Carrillo agreed to lead the California-based cannabis producer Unrivaled Brands, Inc (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/UNRV#OTCQB">UNRV</a>);</li>



<li>iAnthus Capital Holdings, Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/IAN#CSE">IAN</a>) (OTCPK: ITHUF) appointed Richard Proud as CEO and the board&#8217;s director;</li>



<li>PharmaCielo Ltd. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/PCLOF#OTCQX">PCLOF</a>) (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/PCLO#TSXV">PCLO</a>) the Canadian parent of Colombia&#8217;s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. named Marc Lustig as chairman and CEO;</li>



<li>MedMen Enterprises Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/MMEN#CSE">MMEN</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MMNFF#OTCQX">MMNFF</a>) appointed Ellen Deutsch as CEO; and</li>



<li>Flora Growth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGC#NASDAQ">FLGC</a>) tapped <a href="https://www.benzinga.com/markets/cannabis/23/07/33119512/leadership-shake-ups-across-several-weed-companies-who-got-the-top-jobs">Clifford Starke to serve as CEO.</a></li>
</ul>



In September, Charlotte&#8217;s Web (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTCQX">CWBHF</a>) (TSX: CWEB) tapped William Morachnick as CEO, succeeding CEO Jacques Tortoroli, who resigned from <a href="https://www.benzinga.com/markets/cannabis/23/09/34534219/former-reynolds-american-executive-joins-charlottes-web-as-new-ceo">his roles at the Colorado-based company.</a>



Cannabis veteran executive Gary Santo agreed to assume the CEO role at RX Green Technologies in October, <a href="https://www.benzinga.com/markets/cannabis/23/10/35289402/marijuana-veteran-gary-santo-to-lead-denver-maker-of-cannabis-cultivation-inputs-and-services">replacing Wes Matelich</a>. Cannabis-focused commercial real estate finance company AFC Gamma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFCG#NASDAQ">AFCG</a>) wrapped up the month by tapping industry veteran <a href="https://www.benzinga.com/markets/cannabis/23/10/35491822/cannabis-lender-taps-industry-veteran-as-ceo-to-gain-in-house-operating-expertise">Daniel Neville as its new CEO.</a>



In November, the governmental cannabis retail monopoly in the Canadian province of Quebec, the Société québécoise du cannabis (SQDC) named<a href="https://www.benzinga.com/markets/cannabis/23/11/35560804/woman-takes-helm-of-quebecs-cannabis-retail-monopoly-and-more-industry-changes"> Suzanne Bergeron</a> as its new president and CEO. Cannabis vape producer The Blinc Group promoted Pete Sahani, the company's COO since 2022, to <a href="https://www.benzinga.com/markets/cannabis/23/11/36003747/cannabis-industrys-new-mavericks-two-companies-introduce-fresh-leadership">CEO a month ago.</a>



This week, Kaival Brands Innovations Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KAVL#NASDAQ">KAVL</a>) announced that it has expanded the role of Barry M. Hopkins, executive chairman, to include the positions of interim CEO and president.



Missed the first wave of cannabis investments? Don't make that mistake again. Experts believe <a target="_blank" href="https://marketfy.com/item/420investor/" rel="noreferrer noopener">cannabis stocks have found their floor</a> and are now poised for unprecedented growth. Join <a target="_blank" href="https://marketfy.com/item/420investor/" rel="noreferrer noopener">Benzinga PotProfits</a>. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising <a target="_blank" href="https://marketfy.com/item/420investor/#overview-page" rel="noreferrer noopener">cannabis stocks poised for growth</a>, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities! &nbsp;Just this year, the PotProfits <a target="_blank" href="https://marketfy.com/item/420investor/#overview-page" rel="noreferrer noopener">portfolio</a> has seen smoking-hot gains like:



<ul>
<li>&nbsp;47.10% with $GTBIF</li>



<li>&nbsp;40.23% with $TCNNF</li>



<li>&nbsp;21.50% with $VFF</li>
</ul>



&nbsp;But here's the kicker: Michael is about to release his <a target="_blank" href="https://marketfy.com/item/420investor/#overview-page" rel="noreferrer noopener">next potential winners</a>, and he's chomping at the bit to share these ticker symbols with you ASAP.



Don't miss out on the <a target="_blank" href="https://marketfy.com/item/420investor/#overview-page" rel="noreferrer noopener">green rush</a>!

HUMBL (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HMBL#OTC">HMBL</a>) has outperformed the market over the past 5 years by 234.07% on an annualized basis producing an average annual return of 243.22%. Currently, HUMBL has a market capitalization of $39.29 million. 
Buying $100 In HMBL: If an investor had bought $100 of HMBL stock 5 years ago, it would be worth $4,762.50 today based on a price of $0.02 for HMBL at the time of writing.
<h3>HUMBL's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2023/1675884911_0.png" alt="comp_fig" />

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Dividends

Here's How Much $100 Invested In HUMBL 5 Years Ago Would Be Worth Today

Comments

HUMBL

News

Latest news for HUMBL (OTC:HMBL) Stock

Friday, December 29, 2023

Wednesday, February 08, 2023

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga